# Human Dx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/human-dx

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.humandx.org
- Total disclosed funding: $2.8M
- Latest round: Seed (Oct 3, 2013)
- Investors on record: 5

## About

Human Dx, Ltd. is a pioneering organization that leverages the collaborative expertise of medical professionals and advanced machine learning to enhance diagnostic accuracy in healthcare.Founded in 2013 in San Francisco, US, Human Dx focuses on improving diagnostic processes through a community-driven platform. The company raised USD 2.8 mn in a Seed funding round on October 3, 2013, with investments from Andreessen Horowitz, Data Collective, First Round Capital, Kapor Capital, and Union Square Ventures. Tim Surkovich, the founder, has a background in healthcare innovation, aiding the development of Human Dx's strategic direction.The Human Diagnosis Project (Human Dx) offers a platform that utilizes collective intelligence and machine learning to improve diagnostic accuracy. Key features include Insight Cases for real-world medical engagement and the Global Morning Report (GMR) aimed at enhancing clinical reasoning for healthcare professionals. The platform integrates insights from over 100,000 medical professionals across over 500 institutions globally, providing valuable resources for clinicians, medical trainees, and research institutions.Human Dx operates under a transaction-based model, likely involving partnerships with medical institutions and subscriptions for healthcare professionals. The platform's offerings, such as Insight Cases and GMR, facilitate community engagement, allowing medical professionals to earn Impact points, which may grant access to additional resources. This revenue model is designed to foster B2B transactions and direct engagement with healthcare providers, ensuring sustainability in improving diagnostics and educational tools.In October 2013, Human Dx, Ltd. secured USD 2.8 mn in Seed financing, which will support the advancement of its platform and potential new product launches. The company aims to expand into additional markets, focusing on enhancing healthcare delivery in underrepresented regions, utilizing the funding to optimize its offerings and outreach efforts. This financial backing will also aid in developing new features within their existing products, streamlining processes for healthcare professionals globally.

## Funding rounds

- Seed, Oct 3, 2013, $2.8M — Union Square Ventures, First Round Capital, Andreessen Horowitz, Kapor Capital, DCVC

## Investors

- Union Square Ventures (https://capitalatlas.ai/funds/union-square-ventures) — Seed
- First Round Capital (https://capitalatlas.ai/funds/first-round-capital) — Seed
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Seed
- Kapor Capital (https://capitalatlas.ai/funds/kapor-capital) — Seed
- DCVC (https://capitalatlas.ai/funds/dcvc) — Seed